Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.

Ezekowitz MD, Bridgers SL, James KE, Carliner NH, Colling CL, Gornick CC, Krause-Steinrauf H, Kurtzke JF, Nazarian SM, Radford MJ, et al.

N Engl J Med. 1992 Nov 12;327(20):1406-12. Erratum in: N Engl J Med 1993 Jan 14;328(2):148.

2.

Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.

[No authors listed]

Arch Intern Med. 1994 Jul 11;154(13):1449-57. Erratum in: Arch Intern Med 1994 Oct 10;154(19):2254.

PMID:
8018000
3.

Stroke Prevention in Atrial Fibrillation Study. Final results.

[No authors listed]

Circulation. 1991 Aug;84(2):527-39.

PMID:
1860198
5.

Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation.

Pengo V, Zasso A, Barbero F, Banzato A, Nante G, Parissenti L, John N, Noventa F, Dalla Volta S.

Am J Cardiol. 1998 Aug 15;82(4):433-7.

PMID:
9723629
6.
7.

Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis.

Hart RG, Benavente O, McBride R, Pearce LA.

Ann Intern Med. 1999 Oct 5;131(7):492-501.

PMID:
10507957
8.
9.

A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement.

Turpie AG, Gent M, Laupacis A, Latour Y, Gunstensen J, Basile F, Klimek M, Hirsh J.

N Engl J Med. 1993 Aug 19;329(8):524-9.

10.

Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.

Caro JJ, Flegel KM, Orejuela ME, Kelley HE, Speckman JL, Migliaccio-Walle K.

CMAJ. 1999 Sep 7;161(5):493-7. Erratum in: CMAJ 2000 Apr 4;162(7):973.

11.

Preventing stroke in patients with nonrheumatic atrial fibrillation.

Nelson KM, Talbert RL.

Am J Hosp Pharm. 1994 May 1;51(9):1175-83. Review.

PMID:
8042636
12.
15.

Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation.

Copland M, Walker ID, Tait RC.

Arch Intern Med. 2001 Sep 24;161(17):2125-8.

PMID:
11570942
16.

[The randomized study of efficiency and safety of antithrombotic therapy in nonvalvular atrial fibrillation: warfarin compared with aspirin].

Hu DY, Zhang HP, Sun YH, Jiang LQ; Antithrombotic Therapy in Atrial Fibrillation Study Group.

Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Apr;34(4):295-8. Chinese.

PMID:
16776915
17.

Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.

Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.

Am J Geriatr Pharmacother. 2009 Jun;7(3):159-66. doi: 10.1016/j.amjopharm.2009.06.002.

PMID:
19616184
18.

Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.

Ezekowitz MD, James KE, Nazarian SM, Davenport J, Broderick JP, Gupta SR, Thadani V, Meyer ML, Bridgers SL.

Circulation. 1995 Oct 15;92(8):2178-82.

19.

Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.

Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL; SPORTIF Investigators.

Am Heart J. 2006 Nov;152(5):967-73.

PMID:
17070169
20.

Prevention of thromboembolic events in atrial fibrillation.

Koefoed BG, Gulløv AL, Petersen P.

Thromb Haemost. 1997 Jul;78(1):377-81. Review.

PMID:
9198182

Supplemental Content

Support Center